Literature DB >> 4659918

Clinical spectrum of Budd-Chiari syndrome in Chandigrah with particular reference to obstruction of intrahepatic portion of inferior vena cava.

D V Datta, S Saha, S A Singh, B B Gupta, B K Aikat, P N Chhuttani.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 4659918

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  10 in total

1.  Budd-Chiari syndrome: outcomes of endovascular intervention-A single-center experience.

Authors:  Nitin Jagtap; Mithun Sharma; Jagdeesh Singh; Manu Tandan; P N Rao; Rajesh Gupta; Sundeep Lakhtakia; Mohan Ramchandani; Harshal Shah; T Mahesh Kumar; Santosh Darishetty; G V Rao; D N Reddy
Journal:  Indian J Gastroenterol       Date:  2017-06-20

2.  An Idiopathic Membranous IVC Obstruction: Presenting as a Variant of the BCS.

Authors:  Amirtha Ganesh B; Ravi Cherian Mathew; Ananathakrishnan N
Journal:  J Clin Diagn Res       Date:  2013-04-01

Review 3.  Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava).

Authors:  Santosh Man Shrestha
Journal:  World J Hepatol       Date:  2015-04-28

Review 4.  Idiopathic obstruction of the inferior vena cava: a review.

Authors:  E W Benbow
Journal:  J R Soc Med       Date:  1986-02       Impact factor: 5.344

5.  Budd-Chiari syndrome.

Authors:  B R Thapa; B N Walia; Y Chawla; C K Banerjee; S Katariya; R K Marwaha
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

6.  Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava.

Authors:  Santosh Man Shrestha
Journal:  Hepatol Int       Date:  2009-01-23       Impact factor: 6.047

7.  Splenomegaly and hypersplenism in hepatic vena cava syndrome.

Authors:  Santosh Man Shrestha
Journal:  Hepatol Forum       Date:  2021-05-24

8.  Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment.

Authors:  Deepak N Amarapurkar; Sundeep J Punamiya; Nikhil D Patel
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

9.  Long-term Outcome of Budd-Chiari Syndrome: A Single Center Experience.

Authors:  Neda Nozari; Hassan Vossoghinia; Fatemeh Malekzadeh; Lila Kafami; Mahyar Mirheidari; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2013-07

10.  Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.

Authors:  Che-Pei Kung; Kyle A Cottrell; Sua Ryu; Emily R Bramel; Raleigh D Kladney; Emily A Bao; Eric C Freeman; Thwisha Sabloak; Leonard Maggi; Jason D Weber
Journal:  Oncogene       Date:  2020-10-27       Impact factor: 9.867
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.